Department of Histology and Embryology, Faculty of Medicine, Istanbul University, Istanbul, Turkey.
J Neurooncol. 2010 Dec;100(3):385-95. doi: 10.1007/s11060-010-0209-6. Epub 2010 May 14.
The aim of this work is to investigate whether clomipramine (CIM) and lithium chloride (LiCl) potentiate the cytotoxicity of vinorelbine (VNR) on SH-SY5Y human neuroblastoma cells in vitro and whether midkine (MK) can be a resistance factor for these treatments. Four groups of experiments were performed for 96 h using both monolayer and spheroid cultures of SH-SY5Y cells: (1) control group, (2) singly applied VNR, CIM, and LiCl, (3) VNR with CIM, and (4) VNR with LiCl. Their effects on monolayer and spheroid cultures were determined by evaluating cell proliferation, bromodeoxyuridine labeling index (BrdU-LI), apoptosis, cyclic adenosine monophosphate (cAMP) and midkine levels, colony-forming efficiency, spheroid size, and ultrastructure. In comparison with the control group, single and combination drug treatments significantly reduced the proliferation index (PI) for 96 h. The most potent reduction of PI was observed with VNR in combination with CIM and LiCl for all time intervals. VNR with CIM and LiCl seemed to be ineffective in reducing BrdU-LI of both monolayer cell and spheroid cultures, spheroid size, and cAMP level. VNR with LiCl increased apoptosis at 24 h, however VNR with CIM increased apoptosis at 96 h. VNR was the most potent drug in inhibiting colony-forming efficiency. The combination of VNR with CIM was the most potent in reducing midkine levels among all groups. Interestingly, the combination of VNR with LiCl led to both nuclear membrane breakdown and disappearance of the cellular membranes inside the spheroids. Both CIM and LiCl seemed to potentiate VNR-induced cytotoxicity, and MK was not a resistance factor for VNR, LiCl, and CIM.
本工作旨在研究氯米帕明(CIM)和氯化锂(LiCl)是否能增强长春瑞滨(VNR)对体外 SH-SY5Y 人神经母细胞瘤细胞的细胞毒性,以及中期因子(MK)是否可以成为这些治疗的耐药因素。我们使用单层和球体培养的 SH-SY5Y 细胞进行了四组 96 小时的实验:(1)对照组,(2)单独应用 VNR、CIM 和 LiCl,(3)VNR 与 CIM,(4)VNR 与 LiCl。通过评估细胞增殖、溴脱氧尿嘧啶标记指数(BrdU-LI)、凋亡、环磷酸腺苷(cAMP)和中期因子水平、集落形成效率、球体大小和超微结构,来确定它们对单层和球体培养物的影响。与对照组相比,单一和联合药物处理在 96 小时内显著降低了增殖指数(PI)。VNR 与 CIM 和 LiCl 联合使用时,PI 的降低最为明显,所有时间间隔均如此。VNR 与 CIM 和 LiCl 联合使用似乎不能降低单层细胞和球体培养物的 BrdU-LI、球体大小和 cAMP 水平。LiCl 与 VNR 联合使用可在 24 小时时增加凋亡,而 CIM 与 VNR 联合使用则在 96 小时时增加凋亡。VNR 是抑制集落形成效率最有效的药物。VNR 与 CIM 联合使用在降低所有组的中期因子水平方面最为有效。有趣的是,LiCl 与 VNR 联合使用可导致球体内部的核膜破裂和细胞膜消失。CIM 和 LiCl 似乎都增强了 VNR 诱导的细胞毒性,而 MK 不是 VNR、LiCl 和 CIM 的耐药因素。